(NASDAQ: VOR) Vor Biopharma currently has 68,, outstanding shares. With Vor Biopharma stock trading at $ per share, the total value of Vor Biopharma. Vor Biopharma Inc. is a clinical-stage cell and genome engineering therapy company. The Company is engaged in combining a novel patient engineering approach. Vor Biopharma Inc. ; Volume, K ; Market Value, $M ; Shares Outstanding, M ; EPS (TTM), -$ ; P/E Ratio (TTM), N/A. Analyst Price Targets. Consensus. $ Based on analysts offering 12 month price targets for VOR in the last 3 months. The average price target is $ View the VOR premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Vor Biopharma Inc real.
Vor Biopharma Inc. (cryptotrees.site): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Vor Biopharma Inc. | Nasdaq: VOR. Stock Price Forecast. The 6 analysts with month price forecasts for Vor Biopharma stock have an average target of , with a low estimate of and a. Get Vor Biopharma Inc (VOR:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Mult.) Upgrade. Profile Drag and drop to reorder or search profile items. Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel. VOR - Vor Biopharma Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqGS). The forecasts range from a low of $ to a high of $ A stock's price target is the price at which analysts consider it fairly valued with respect to. Shield the healthy cells, expose the cancer - Vor Bio (also known as Vor Biopharma) aims to cure blood cancers through cell and genome engineering. VOR's current price target is $ Learn why top analysts are making this stock forecast for Vor Biopharma at MarketBeat. Discover real-time Vor Biopharma Inc. Common Stock (VOR) stock prices, quotes, historical data, news, and Insights for informed trading and investment. Track Vor Biopharma Inc (VOR) Stock Price, Quote, latest community messages, chart, news and other stock related information.
Will Vor Biopharma (NASDAQ:VOR) Spend Its Cash Wisely? (Simply Wall St.) Oct AM · Vor Bio. Vor Biopharma has % upside potential, based on the analysts' average price target. Vor Biopharma has a consensus rating of Strong Buy which is based on. Get the latest Vor Biopharma Inc. (VOR) stock news and headlines to help you in your trading and investing decisions. The stock price for Vor Biopharma (NASDAQ: VOR) is $ last updated August 9, at PM EDT. Q. Does Vor Biopharma (VOR). View Vor Biopharma, Inc. VOR stock quote prices, financial information, real-time forecasts, and company news from CNN. PROFILE (VOR). Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel. The latest Vor Biopharma stock prices, stock quotes, news, and VOR history to help you invest and trade smarter. Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution. Is Vor Biopharma Inc. stock A Buy? Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may.
VOR Stock Overview · Revenue is forecast to grow % per year · Has less than 1 year of cash runway · Makes less than USD$1m in revenue ($0) · Currently. VOR | Complete Vor Biopharma Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. View the real-time VOR price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees. Vor Biopharma Inc is currently not in a favorable trading position (SELL) according to technical analysis indicators. More on Technical Analysis. Peers. Loading chart ; About Vor Biopharma Inc. Common Stock (VOR). Loading info ; Key Statistics. Loading info ; News. Loading info.
Defi Derivatives | Tesla Per Share